Thursday, June 25, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 881 of 1,261

  1. US 8399445

    Acetylcysteine composition and uses thereof

    Cumberland Pharmaceuticals Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  2. US 8399449

    Fused heterocyclic derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  3. US 8399458

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  4. US 8399478

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  5. US 8399479

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  6. US 8399501

    Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof

    Theravance, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  7. US 8399493

    Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors

    Addex Pharmaceuticals S.A. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  8. US 8398989

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  9. US 8399018

    Controlled release ion channel modulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  10. US 8399428

    Nucleosides with antiviral and anticancer activity

    Regents of the University of Minnesota · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  11. US 8399488

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  12. US 8399512

    Biocompatible biodegradable fumagillin analog conjugates

    Mersana Therapeutics, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  13. US 8399615

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  14. US 8399609

    Treating or preventing extracellular matrix build-up

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  15. US 8399666

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  16. US 8399610

    HPV vaccine comprising peptides from host cell proteins

    University College Cardiff Consultants Limited · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  17. US 8399689

    Chrysophaentin antimicrobial compounds that inhibit FtsZ protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  18. US 8394357

    Optical determination of glucose utilizing boronic acid adducts

    The Regents of the University of California · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  19. US 8394377

    Methods for treating cancer using combination therapy

    The Regents of the University of Colorado · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  20. US 8394762

    Self-decontaminating coatings containing antimicrobial peptides

    United States of America as represented by the Secretary of the Air Force · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  21. US 8394846

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  22. US 8394803

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  23. US 8394794

    Therapeutic compounds

    Regents of the University of Minnesota · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  24. US 8394788

    Phenylsulfoxyoxazole compound inhibitors of urea transporters

    The Regents of the University of California · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.